A notable advancement in diabetes management is emerging with the introduction of tirzepatide at a dosage of 45mg. This updated formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, https://enrollbookmarks.com/story21253541/revolutionary-development-tirzepatide-dose-for-diabetes-control